Michele Ammendola Selected Research

Tryptases (Tryptase)

1/2021	Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue.
4/2018	Tumor-Associated Macrophages and Mast Cells Positive to Tryptase Are Correlated with Angiogenesis in Surgically-Treated Gastric Cancer Patients.
1/2018	C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients.
9/2017	The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients.
4/2017	Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance.
11/2016	Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery.
1/2016	Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery.
1/2016	Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery.
10/2015	Targeting mast cells in gastric cancer with special reference to bone metastases.
5/2015	Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michele Ammendola Research Topics

Disease

24	Neoplasms (Cancer) 01/2021 - 07/2009
8	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2013
7	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2014
7	Stomach Neoplasms (Stomach Cancer) 04/2019 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2014
3	Hyperthermia 01/2020 - 01/2020
3	Rectal Neoplasms (Rectal Cancer) 02/2019 - 01/2014
3	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2009
2	Hypoxia (Hypoxemia) 01/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 09/2020 - 02/2014
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2020
2	Adenocarcinoma 09/2017 - 01/2014
2	Prolapse 09/2014 - 07/2013
2	Hypersensitivity (Allergy) 07/2014 - 01/2014
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021
1	Fibrosarcoma 12/2020
1	Carcinogenesis 09/2020
1	Hypertrophy 01/2020
1	Infarction (Infarctions) 01/2020
1	Liver Failure 01/2019
1	Protein Deficiency 01/2019
1	Ascites 01/2019
1	Wounds and Injuries (Trauma) 02/2017
1	Gangrene 02/2017
1	Infections 02/2017
1	Diabetic Foot 02/2017
1	Lymphatic Metastasis 11/2016
1	Bone Resorption 10/2015
1	Liver Neoplasms (Liver Cancer) 05/2015
1	Myxoma (Myxomas) 07/2014
1	Dermatofibrosarcoma 02/2014
1	Vomiting 12/2013
1	Dermatitis 12/2013
1	Asthenia 12/2013

Drug/Important Bio-Agent (IBA)

21	Tryptases (Tryptase)IBA 01/2021 - 07/2009
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
6	Biological ProductsIBA 01/2021 - 01/2014
4	Gabexate (Foy)IBA 01/2021 - 01/2013
4	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2018 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2013
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 02/2014
3	Peptide Hydrolases (Proteases)FDA Link 04/2017 - 01/2014
3	nafamostatIBA 10/2015 - 01/2013
3	S- (N- monomethoxytritylaminoethyl)- O- (2- chlorophenyl)phosphorothioateIBA 10/2015 - 01/2013
3	Serine Proteases (Serine Protease)IBA 07/2014 - 07/2009
2	masitinibIBA 01/2021 - 10/2015
2	degradable starch microspheresIBA 01/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 10/2015 - 02/2014
1	Ethiodized Oil (Ethiodol)FDA Link 01/2021
1	ParaffinIBA 12/2020
1	Formaldehyde (Formol)FDA Link 12/2020
1	Immunologic Factors (Immunomodulators)IBA 09/2020
1	MicroRNAs (MicroRNA)IBA 09/2020
1	Intravenous AnestheticsIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Opiate AlkaloidsIBA 01/2020
1	Local AnestheticsIBA 01/2020
1	Anesthetics (Anesthetic Agents)IBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor CIBA 04/2019
1	LigandsIBA 04/2019
1	IronIBA 01/2019
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 09/2017
1	2,2,3,3-tetramethylcyclopropane carboxamideIBA 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Angiogenesis InhibitorsIBA 01/2015
1	PAR-2 ReceptorIBA 07/2014
1	pazopanib FDA Link 02/2014
1	tranilastIBA 01/2014

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2014
2	Transplantation 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020
2	Proctectomy 02/2019 - 01/2016
2	Contraindications 02/2019 - 01/2016
2	Lasers (Laser) 09/2014 - 07/2013
2	Optical Fibers 09/2014 - 07/2013
1	Liver Transplantation 01/2021
1	Colectomy 12/2020
1	Precision Medicine 09/2020
1	Electrodes (Electrode) 01/2020
1	Immunomodulation 01/2020
1	Perioperative Period 01/2020
1	Radiotherapy 01/2020
1	Analgesia 01/2020
1	Operative Time 01/2019
1	Length of Stay 01/2019
1	Surgical Amputation (Amputations) 02/2017
1	Stents 01/2017
1	Salvage Therapy 01/2016